Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content.
You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

Managing your cookies

Our website uses cookies. You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button.

Necessary cookies

These are essential for the user navigation and allow to give access to certain functionalities such as secured zones accesses. Without these cookies, it won’t be possible to provide the service.
Matomo on premise

Marketing cookies

These cookies are used to deliver advertisements more relevant for you, limit the number of times you see an advertisement; help measure the effectiveness of the advertising campaign; and understand people’s behavior after they view an advertisement.
Adobe Privacy policy | Marketo Privacy Policy | MRP Privacy Policy | AccountInsight Privacy Policy | Triblio Privacy Policy

Social media cookies

These cookies are used to measure the effectiveness of social media campaigns.
LinkedIn Policy

Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

Skip to main content

Senegal’s UVS uses Atos’ BullSequana Intel-based supercomputer to evaluate impact of COVID-19 containment measures

Paris, November 26, 2020

Atos announces that the Virtual University of Senegal (UVS) is testing a mathematical algorithm which models the spread of COVID-19, to evaluate the impact of containment measures such as social distancing and wearing masks, using Atos’ BullSequana X800 supercomputer. This supercomputer, based on 2nd Gen Intel® Xeon® Platinum processors is accessible through Atos’ new HPC, AI, and Quantum Life Sciences Centre of Excellence (LSCoE). Intel Corporation, among others, has provided funding for this project.

“We have already made an important step forward in modelling the spread of the virus for the Senegalese territory. With the compute capabilities and expertise provided by Atos’ BullSequana HPC platform, we hope to accelerate the simulation of a combination of different containment measures and identify those that are more convenient.” said Abdou Sene, Professor of Applied Mathematics, Head of the Pole of Innovation and Expertise for Development (PIED) at the Virtual University of Senegal “In particular, we have applied the model at a regional scale for Senegal and therefore in order to carry out simulations we aggregated the different systems used by each region into one. Moreover, the model has been age-structured, which multiplies the size of the system by the number of age groups considered. Simulating such a model with accurate data might give evidence of the reason why the pandemic does not have the same evolution in the different regions of the world.”

The Virtual University of Senegal is one of the first users of this platform. In line with the Senegalese health authorities’ strategy, renowned researchers at the Pole of Innovation and Expertise for Development (PIED) of UVS have created a theoretical mathematical model able to simulate different scenarios in the spread of COVID-19 and needed advanced computer resources to run multiple simulations.

“Advanced computing platforms like Atos’ BullSequana have played a critical role in studying SARS-CoV-2,” said Trish Damkroger, Vice President and General Manager of High Performance Computing at Intel. “Providing Atos and the UVS with the latest Intel-based compute technologies is allowing researchers to harness tremendous amounts of data to simulate the spread of COVID-19 and evaluate the best approaches to limit its transmission.”

By accessing Atos’ leading-edge technologies, such as Quantum, High Performance Computing and AI, supported by Atos’ services and expertise, together with this Atos-Intel HPC platform, researchers at UVS are now able to test their model by using different scenarios to measure the impact of containment measures. The model includes a quarantined population variable and looks at the survival of SARS-CoV-2 on surfaces.

“This new HPC platform, which has been made accessible through Atos’ HPC, AI, and Quantum Life Sciences Centre of Excellence, represents a very good opportunity for those like the UVS working on projects that require high in-memory capabilities.” said Alpha Barry, CEO of Atos in Africa “We’re proud to be able to support researchers in Senegal to help advance research to find out more about how the COVID-19 virus behaves and support the fight against this global pandemic.”

This platform is available to all universities and laboratories worldwide working in SARS-Cov-2 related projects and it illustrates the first milestone in the new Atos-Intel partnership in Life Sciences in which Intel provides funding for a platform that is fully managed and operated by Atos experts.

Intel is committed to accelerating access to technology that can combat the current pandemic and enable scientific discovery that better prepares our world for future crises. This solution was funded in part by Intel’s Pandemic Response Technology Initiative. For more information about healthcare solutions from Intel, visit intel.com/healthcare. For more information about Intel’s COVID-19 response, visit intel.com/COVID-19.

***

Technical specifications

BullSequana X800 supercomputer

8 sockets 2nd Gen Intel® Xeon® Scalable processors (Platinum 8280) with a total of 224 cores)

6 TB of shared memory

About Atos

Atos is a global leader in digital transformation with 110,000 employees in 73 countries and annual revenue of € 12 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos|Syntel, and Unify. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index.

The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

Press contact:

Laura Fau | laura.fau@atos.net | +33 6 73 64 04 18 | @laurajanefau

Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.